The ongoing Ebola outbreak may be more severe than reported by official sources, according to Oxfam. The humanitarian organization raises concerns about shortages of essential supplies in areas at the heart of the outbreak in central Africa, potentially hindering efforts to contain the deadly virus.
Adding to the complexity is that this outbreak stems from the Bundibugyo strain of the Ebola virus, which is a rare and highly lethal variant with no approved vaccines or treatments available, carrying a fatality rate of up to 40%.
Early detection and supportive care, such as hydration, are critical in improving survival rates and reducing transmission. Access to clean water is a fundamental requirement for these efforts.
Oxfam’s field data reveals limited access to clean water in the outbreak’s epicenter, with sanitation and water systems crucial for virus containment collapsing. Manel Rebordosa, Oxfam’s Field Response Coordinator, highlights the lack of clean water as a significant challenge in the region, with miners lacking basic hygiene facilities and returning to communities already battling the virus.
The Bundibugyo virus spreads through direct contact with infected bodily fluids, necessitating preventive measures like avoiding contact with infected individuals and maintaining proper hygiene practices. However, access to clean water is essential for implementing these measures effectively.
In Mongbwalu, a town at the outbreak’s epicenter, only a small percentage of the population has access to clean water and functional sanitation facilities, reflecting a significant challenge in containing the outbreak.
Oxfam warns that the true scale of the outbreak may exceed reported figures, a concern further emphasized by the US Centers for Disease Control and Prevention confirming this as the largest Bundibugyo outbreak on record. Decreased humanitarian funding in the Democratic Republic of Congo has exacerbated the situation, leading to shortages of essential supplies and affecting response efforts.
Efforts are underway to explore existing Ebola treatments for potential efficacy against this strain, with the WHO recommending the prioritization of experimental drugs for treating and preventing this specific virus strain.